Total Payments
$3,941
2023 Payments
$344.25
Companies
20
Transactions
152
Medicare Patients
919
Medicare Billing
$452,105
Payment Breakdown by Category
Food & Beverage$3,835 (97.3%)
Education$105.96 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,835 | 150 | 97.3% |
| Education | $105.96 | 2 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $952.71 | 27 | $0 (2023) |
| UCB, Inc. | $602.09 | 30 | $0 (2023) |
| Amgen Inc. | $337.00 | 13 | $0 (2022) |
| Genentech USA, Inc. | $324.80 | 7 | $0 (2022) |
| Horizon Therapeutics plc | $323.14 | 4 | $0 (2022) |
| Janssen Biotech, Inc. | $307.21 | 22 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $241.57 | 8 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $164.41 | 8 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $118.10 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $104.83 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $344.25 | 12 | UCB, Inc. ($145.64) |
| 2022 | $2,145 | 85 | ABBVIE INC. ($479.47) |
| 2021 | $926.49 | 47 | AbbVie Inc. ($238.76) |
| 2020 | $185.22 | 3 | Horizon Therapeutics plc ($169.56) |
| 2019 | $245.61 | 4 | Genentech USA, Inc. ($219.17) |
| 2018 | $94.23 | 1 | AbbVie, Inc. ($94.23) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: ANTIBIOTICS | ||||||
| 03/02/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Immunology | ||||||
| 03/01/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Immunology | ||||||
| 02/27/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: Immunology | ||||||
| 02/01/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Immunology | ||||||
| 01/31/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Immunology | ||||||
| 01/25/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $47.40 | General |
| Category: Immunology | ||||||
| 01/18/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Immunology | ||||||
| 01/12/2023 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Immunology | ||||||
| 01/10/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $110.54 | General |
| 01/03/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Immunology | ||||||
| 12/07/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Bone Health | ||||||
| 12/02/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Immunology | ||||||
| 11/18/2022 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Immunology | ||||||
| 11/18/2022 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: Immunology | ||||||
| 11/16/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Immunology | ||||||
| 11/16/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Immunology | ||||||
| 11/14/2022 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Inflammation | ||||||
| 11/09/2022 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Inflammation | ||||||
| 11/08/2022 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: Inflammation | ||||||
| 10/27/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Immunology | ||||||
| 10/25/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $124.26 | General |
| 10/19/2022 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Rare Disease | ||||||
| 10/14/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 240 | 10,351 | $239,665 | $57,557 |
| 2022 | 9 | 406 | 43,323 | $858,772 | $248,316 |
| 2021 | 9 | 273 | 14,396 | $277,814 | $146,231 |
Total Patients
919
Total Services
68,070
Medicare Billing
$452,105
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 11 | 10,003 | $160,016 | $39,223 | 24.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 87 | $19,227 | $5,269 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 75 | $24,675 | $3,959 | 16.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $14,856 | $3,187 | 21.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 35 | 59 | $7,139 | $2,235 | 31.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 32 | 33 | $7,392 | $2,038 | 27.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 13 | $4,251 | $1,138 | 26.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 57 | $2,109 | $507.64 | 24.1% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 13 | 42,400 | $661,600 | $191,926 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 349 | $114,711 | $34,973 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 75 | 75 | $30,379 | $7,589 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 138 | $27,714 | $6,795 | 24.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 19 | 57 | $10,133 | $3,125 | 30.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 31 | 232 | $9,427 | $2,528 | 26.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 26 | $4,391 | $1,241 | 28.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 13 | 26 | $377.00 | $130.08 | 34.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 12 | 20 | $40.00 | $10.63 | 26.6% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 11 | 12,400 | $124,000 | $62,780 | 50.6% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 11 | 1,625 | $97,500 | $56,162 | 57.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 82 | 82 | $24,600 | $10,905 | 44.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 60 | $8,700 | $6,309 | 72.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 83 | $10,375 | $6,138 | 59.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 14 | 26 | $4,758 | $1,483 | 31.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 15 | 28 | $4,396 | $1,481 | 33.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 21 | 79 | $3,160 | $914.03 | 28.9% |
About Dr. Marco Lopez Velazquez, M.D
Dr. Marco Lopez Velazquez, M.D is a Rheumatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1316399264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marco Lopez Velazquez, M.D has received a total of $3,941 in payments from pharmaceutical and medical device companies, with $344.25 received in 2023. These payments were reported across 152 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,835).
As a Medicare-enrolled provider, Lopez Velazquez has provided services to 919 Medicare beneficiaries, totaling 68,070 services with total Medicare billing of $452,105. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Hospitalist, Internal Medicine
- Location Austin, TX
- Active Since 07/04/2016
- Last Updated 11/12/2024
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316399264
Products in Payments
- Cimzia (Drug) $602.09
- RINVOQ (Biological) $566.58
- KRYSTEXXA (Biological) $323.14
- Rituxan (Biological) $310.35
- REMICADE (Biological) $247.77
- SAPHNELO (Biological) $241.57
- TREMFYA (Drug) $177.54
- EVENITY (Biological) $176.04
- ORENCIA (Biological) $164.41
- Enbrel (Biological) $160.96
- TALTZ (Drug) $103.18
- Humira (Biological) $94.23
- ACTHAR (Biological) $93.35
- BENLYSTA (Biological) $85.20
- COSENTYX (Biological) $70.51
- RENFLEXIS (Drug) $53.32
- SKYRIZI (Biological) $45.60
- CUVITRU (Biological) $27.09
- STRENSIQ (Biological) $24.93
- ILARIS (Biological) $22.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Austin
Dr. Robert Koval, Md, MD
Rheumatology — Payments: $67,062
Rheumatology $67,062
Paul Pickrell, Md, MD
Rheumatology — Payments: $29,321
Rheumatology $29,321
Joseph Martinez, Md, MD
Rheumatology — Payments: $21,904
Rheumatology $21,904
Dr. Louis Robinett, M.d, M.D
Rheumatology — Payments: $6,520
Rheumatology $6,520
Sonia Yousuf, Md, MD
Rheumatology — Payments: $2,974
Rheumatology $2,974
Dr. Samir Patel, M.d, M.D
Rheumatology — Payments: $1,565
Rheumatology $1,565